Beta Bionics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +209.7% | +36.0% | +119.7% | |
| – | +264.0% | +28.3% | +101.5% | |
| – | -4.0% | +14.6% | +3.8% | |
| – | +249.6% | +7.1% | +111.6% | |
| – | – | +169.7% | +65.8% | |
| – | – | +969.9% | +63.1% | |
| – | -75.0% | +43.2% | -44.1% | |
| – | +19.5% | +99.4% | +46.2% | |
| – | +25.4% | +24.9% | +26.7% | |
| – | +171.2% | +144.6% | +75.2% | |
| – | – | +29.7% | +278.4% | |
| – | – | – | – | |
| – | +0.0% | +0.0% | -5.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.